Navigation Links
Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group
Date:9/23/2010

TORONTO, Sept. 23 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Latin American physicians will increasingly adopt abdominal and thoracic endovascular aortic repair in place of surgical repair through 2015 as awareness of the benefits of endovascular techniques grows and physician training improves.

Thoracic endovascular aortic repair tends to be a slightly more attractive option for physicians and patients because the alternative open surgical procedure is associated with significant mortality, complications, and longer hospital stays. Conversely, newer thoracic aortic stent grafts incorporate features that add to their versatility in treating a variety of thoracic aortic conditions, including aneurysms and dissections. These features include improved deliverability and reliability of stent graft placement, which make it easier for physicians to treat a diverse patient population.  Abdominal endovascular aortic repair, in contrast, will face more competition from surgical options because the latter is not quite as risky in the abdominal aorta compared to in the thoracic aortic. As a result, surgical repair of the abdominal aorta will continue to be preferred in some centers due to the high cost of aortic stent grafts. Although budget constraints among Latin American health care facilities will remain a limiting factor, the aortic stent graft market is set to expand to more than $150 million by 2015.

"Mexico, in particular, has traditionally experienced lower stent graft penetration rates compared to other Latin American countries due to its slow device approval process," says Fareed Hameed, Analyst at MRG.  "Because device approval has lagged behind some other regions, physician training on endovascular repair procedures has also been lower; however, even Mexico will see growth in aortic stent graft procedures of approximately 15% per year through 2015
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
4. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
5. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
6. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
7. SuperGens Novel Hypomethylating Agent Highlighted at AACR Plenary Session
8. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
9. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
10. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
11. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD; ... treatment of chronic pain, announced today that the company,s ... FBR Second Annual Healthcare Conference and BioCentury NewsMakers Conference.  ... FBR Second Annual Healthcare Conference Date:  Wednesday, September ... No presentation, investor meetings only ...
(Date:9/2/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... of new cancer therapies, today announced that it ... of the Mechanisms and Cytotoxic Activity of Dianhydrogalactitol ... Wild-type and Mutant p53," at the American ...
(Date:9/2/2015)... Ascletis announced today the completion of a US$35 million ... C-Bridge Capital, joined by Tasly Pharmaceutical and ... Company before financing was US$300 million. The ... Ascletis, pipeline, strengthen global development capabilities and enhance GMP ... investors, Ascletis is now entering an exciting new era. ...
Breaking Medicine Technology:Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 3DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 4Ascletis Secures US$35 Million Financing 2Ascletis Secures US$35 Million Financing 3
... MRSA School Scare Every day brings new reports ... -- of MRSA (methicillin-resistant staphylococcus aureus),a potentially lethal form ... and colleges. The most prominent symptoms,include skin abscesses and/or ... care facilities and attacks,those with low immune systems, children ...
... Nov. 8 Total daily dosages of milnacipran ... clinically,meaningful improvements in both pain and other core ... III data presented,this week at the 2007 American ... effects of milnacipran among responders in a six-month,study ...
Cached Medicine Technology:An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R) 2An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R) 3Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 2Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 3Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 4Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 5Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 6Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 7Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 8
(Date:9/2/2015)... ... September 02, 2015 , ... Density measurement is used in ... sample handling makes density measurements more efficient and error-free. The new METTLER TOLEDO ... workflow and the advantages compared to manual sample handling. , The Evolution of ...
(Date:9/2/2015)... ANGELES, CA (PRWEB) , ... September 02, 2015 , ... ... comedy that will feature a plus-size actress as the primary love interest in the ... media, especially television and film, significantly affects how and what we think,” Michael Elliot, ...
(Date:9/2/2015)... ... September 02, 2015 , ... The ... and allopathic medicine, opens its second location this week at 31542 S. Coast ... square feet of lounge space for patients to relax while receiving safe and ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... clinical staffing companies, has completed a recapitalization with new investment partners Beecken ... and Heritage Group each offer extensive expertise and connections within the healthcare ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... (COIES) is officially announced today. The two day international investment and business conference ... House Oct 9-11, 2015 in Beijing China. The full-weekend networking conference will feature ...
Breaking Medicine News(10 mins):Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2
... 22 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc., (NYSE AMEX: ... Chinese medicine ("TCM") based in Chengdu, China, today,announced that ... when, according,to a preliminary list of additions posted on ... ("Russell") reconstitutes its,comprehensive set of U.S. and global equity ...
... 22 DIA 45th Annual Meeting -- , , News ... In a new report, IDC Health Insights ... healthcare and life science markets, ranked Oracle as the number one vendor ... The Life Science Software Top 10 identifies the 10 leading ...
... VNA,s Hospice of ... ... are the adjectives Hospice of Philadelphia considered when it developed its new free-standing inpatient hospice ... not always possible. Typically, patients requiring acute care must go to a hospital. ...
... , SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- BioMed Realty ... of a new $18 million loan secured by the company,s 9865 ... of 9865 Towne Centre Drive, a state-of-the-art laboratory and office facility, ... has since received LEED(R) Silver certification for Core and Shell from ...
... June 22 United Spinal Association,s ( www.UnitedSpinal.org ) ... region,s premiere lifestyle-enhancing Expo designed to promote active living and independence ... The Independence Expo will be held on Friday, August 7th and ... in Orlando, FL. , , Pre-register at ...
... TAIPEI, Taiwan, June 22 /PRNewswire-Asia/ -- ... announced the signing of a Memorandum of,Understanding (MOU) ... Center (STPI), a non-profit organization under the National,Applied ... provide,direction and support for Taiwan,s Science & Technology ...
Cached Medicine News:Health News:Tianyin Pharmaceutical Co., Inc. Set to Join Russell Microcap(R) Index 2Health News:Tianyin Pharmaceutical Co., Inc. Set to Join Russell Microcap(R) Index 3Health News:Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 2Health News:Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 3Health News:Unique Facility Designed for the Comfort of Hospice Patients and Their Families 2Health News:Unique Facility Designed for the Comfort of Hospice Patients and Their Families 3Health News:BioMed Realty Trust Closes New $18 Million Secured Loan 2Health News:BioMed Realty Trust Closes New $18 Million Secured Loan 3Health News:United Spinal Association's 2009 Independence Expo Aug. 7th-8th In Orlando: Improving Life for the Disabled and the Aging 2Health News:Taiwan's Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development 2Health News:Taiwan's Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development 3
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
Medicine Products: